Literature DB >> 26355821

CHORIORETINAL ATROPHY IN ALAGILLE SYNDROME.

Daniel D Esmaili1.   

Abstract

PURPOSE: To describe multimodal imaging findings in a patient with Alagille syndrome and associated chorioretinopathy.
METHODS: In this case report, clinical examination and multimodal imaging, including fundus photography, spectral domain optical coherence tomography, and fundus autofluorescence (AF) and wide-field AF, are presented.
RESULTS: An 18-year-old Iranian-American girl with known history of Alagille syndrome reported diminished vision in both eyes. Color photographs depicted diffuse hypopigmentation of the fundus and atrophy of the macular retinal pigment epithelium with foveal sparing. Spectral domain optical coherence tomography revealed attenuation of the retinal pigment epithelium and overlying ellipsoid band. Fundus AF imaging of the macula revealed a geographic area of decreased AF that extended to the peripapillary region and inferotemporal arcade and contained discernable ovoid areas of deep AF loss in the nasal macula. Wide-field AF revealed a continuous and circumferential area of well-delineated decreased AF in the retinal periphery of both eyes.
CONCLUSION: This case represents a severe manifestation of posterior and peripheral chorioretinopathy in a patient with Alagille syndrome. This is the first documentation of significant peripheral chorioretinal atrophy as assessed by wide-field AF imaging in this condition.

Entities:  

Mesh:

Year:  2015        PMID: 26355821     DOI: 10.1097/ICB.0000000000000208

Source DB:  PubMed          Journal:  Retin Cases Brief Rep        ISSN: 1935-1089


  2 in total

1.  Ultra-widefield and anterior-segment optical coherence tomography in Alagille syndrome.

Authors:  Nobuhiro Kato; Masatoshi Haruta; Ryuta Takase; Yoriko Watanabe; Shigeo Yoshida
Journal:  Am J Ophthalmol Case Rep       Date:  2021-09-21

2.  Atypical Focal Choroidal Excavation with Macular Hole in a Patient with Alagille Syndrome.

Authors:  Manami Misawa; Hironobu Tampo; Shinji Makino
Journal:  Case Rep Ophthalmol Med       Date:  2022-09-05
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.